Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Globus Medical Inc. Class A Common Stock (GMED) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance

Globus Medical Inc. Class A Common StockTrade
Invesco NASDAQ 100 ETFTrade

Price performance (Past 24H)

Key statistics

Globus Medical Inc. Class A Common Stock vs Invesco NASDAQ 100 ETF — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Invesco NASDAQ 100 ETF trades at $297.07 (market cap $111.77B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 10.9× Globus Medical Inc. Class A Common Stock's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Invesco NASDAQ 100 ETF for 56 Days on average.

GMEDQQQM
Market Cap
$10.25B$111.77B
Volume
1,108,1242,346,098
Sector
HealthBroad Market / Factor
52-Week High
$96.82$312.76
52-Week Low
$58.33$229.87
Typical Hold Time
0 Days56 Days
Enterprise Value
$9.76B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Globus Medical Inc. Class A Common Stock

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Invesco NASDAQ 100 ETF

QQQM trades at $306.18, down 0.33% with a bullish technical signal from moving averages. The ETF's lower 0.15% expense ratio compared to QQQ's 0.18% provides a cost advantage, though trading spreads may offset this benefit. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% in Q2 2026. Technical indicators show neutral oscillators with key support at $304-$306 and resistance at $308-$310.

QQQM offers exposure to Nasdaq-100 growth stocks with competitive fees, but faces competition from alternatives like SCHG and QQQE. The ETF's performance depends on technology sector leadership, with concentration risk in top holdings. Recent news highlights tax implications of similar ETFs, emphasizing the importance of understanding distribution characteristics for long-term returns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GMED
100% Buy0% Sell
Avg holding period · 0 Days
QQQM
90% Buy10% Sell
Avg holding period · 56 Days

Top news

Latest headlines on both assets

About Globus Medical Inc. Class A Common Stock

Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.

Read more on GMED →

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.

Read more on QQQM →